The relationship between synaptic density marker SV2A, glutamate and N-acetyl aspartate levels in healthy volunteers and schizophrenia: a multimodal PET and …
EC Onwordi, T Whitehurst, A Mansur, B Statton… - Translational …, 2021 - nature.com
Glutamatergic excitotoxicity is hypothesised to underlie synaptic loss in schizophrenia
pathogenesis, but it is unknown whether synaptic markers are related to glutamatergic …
pathogenesis, but it is unknown whether synaptic markers are related to glutamatergic …
[HTML][HTML] Synaptic terminal density early in the course of schizophrenia: An in vivo UCB-J positron emission tomographic imaging study of SV2A
Background The synaptic hypothesis is an influential theory of the pathoetiology of
schizophrenia (SCZ), which is supported by the finding that there is lower uptake of the …
schizophrenia (SCZ), which is supported by the finding that there is lower uptake of the …
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats
Synaptic dysfunction is hypothesised to play a key role in schizophrenia pathogenesis, but
this has not been tested directly in vivo. Here, we investigated synaptic vesicle glycoprotein …
this has not been tested directly in vivo. Here, we investigated synaptic vesicle glycoprotein …
In vivo evidence of lower synaptic vesicle density in schizophrenia
Decreased synaptic spine density has been the most consistently reported postmortem
finding in schizophrenia (SCZ). A recently developed in vivo measure of synaptic vesicle …
finding in schizophrenia (SCZ). A recently developed in vivo measure of synaptic vesicle …
Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study
HA Nasrallah, TE Skinner, P Schmalbrock… - The British Journal of …, 1994 - cambridge.org
BackgroundRecent post-mortem and magnetic resonance imaging (MRI) studies strongly
suggest a decrease in the volume of the hippocampus and other limbic temporal structures …
suggest a decrease in the volume of the hippocampus and other limbic temporal structures …
[HTML][HTML] Medial prefrontal cortex glutamate is reduced in schizophrenia and moderated by measurement quality: a meta-analysis of proton magnetic resonance …
Background Magnetic resonance spectroscopy studies measuring brain glutamate
separately from glutamine are helping elucidate schizophrenia pathophysiology. An …
separately from glutamine are helping elucidate schizophrenia pathophysiology. An …
Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes
OD Howes, C Cummings, GE Chapman… - …, 2023 - nature.com
Over the last five decades, a large body of evidence has accrued for structural and metabolic
brain alterations in schizophrenia. Here we provide an overview of these findings, focusing …
brain alterations in schizophrenia. Here we provide an overview of these findings, focusing …
Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study
A Bertolino, JH Callicott, I Elman, VS Mattay… - Biological …, 1998 - Elsevier
Background: Proton magnetic resonance spectroscopic imaging (1H-MRSI) studies have
reported reductions of N-acetyl aspartate (NAA), a marker of neuronal integrity, in the …
reported reductions of N-acetyl aspartate (NAA), a marker of neuronal integrity, in the …
Reduced Frontal Glutamate + Glutamine and N-Acetylaspartate Levels in Patients With Chronic Schizophrenia but not in Those at Clinical High Risk for Psychosis or …
T Natsubori, H Inoue, O Abe, Y Takano… - Schizophrenia …, 2014 - academic.oup.com
Abstract Changes in brain pathology as schizophrenia progresses have been repeatedly
suggested by previous studies. Meta-analyses of previous proton magnetic resonance …
suggested by previous studies. Meta-analyses of previous proton magnetic resonance …
Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia
BACKGROUND: Converging evidence in schizophrenia points to disruption of the dopamine
and glutamate neurotransmitter systems in the pathophysiology of the disorder. Dopamine is …
and glutamate neurotransmitter systems in the pathophysiology of the disorder. Dopamine is …